Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like 5 Biotechs Releasing Highly-Anticipated Data at ASCO May 18, 2017 Why This Pharma May be the Best CAR-T Bet, Not Gilead October 19, 2017 Vivasure Medical Enrolls First Patient In Frontier IV Clinical Trial October 12, 2017
